PIRAMAL PHARMA
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Piramal Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.65₹ 4.20
As on Feb 9, 2026, 4:01 PM IST
Piramal Pharma Price Performance
Today's LowToday's High
₹158.45₹163.25
₹162.85
52 Weeks' Low52 Weeks' High
₹148.30₹241.00
₹162.85
Open Price
₹161.65
Prev. Close
₹158.65
Volume
91,405
Over the last 5 years, the share price of Piramal Pharma has declined 2.76% CAGR. Over the past year, the corresponding return has been -28.12%.
Piramal Pharma’s current P/E of -132.40x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Piramal Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Piramal Pharma | 5.37 | -9.95 | -18.17 | -15.07 | -28.12 | 19.36 | -2.76 |
| Sun Pharmaceutical Industries | 6.87 | -4.37 | 0.70 | 6.63 | -2.57 | 19.23 | 21.85 |
| Divi's Laboratories | 1.03 | -7.91 | -8.11 | -0.27 | -0.39 | 30.55 | 10.09 |
| Torrent Pharmaceuticals | 0.97 | -2.28 | 11.69 | 11.15 | 22.66 | 37.59 | 23.72 |
| Cipla | 1.40 | -8.51 | -10.77 | -9.99 | -8.82 | 9.19 | 9.63 |
| Dr. Reddy's Laboratories | 4.42 | 2.39 | 5.56 | 5.96 | 2.55 | 12.72 | 5.55 |
| Lupin | 2.76 | -0.14 | 12.12 | 13.57 | 0.50 | 43.25 | 15.62 |
| Zydus Lifesciences | 3.99 | -0.72 | -2.46 | -2.62 | -7.38 | 24.29 | 14.23 |
| Mankind Pharma | -1.81 | -9.74 | -7.81 | -17.92 | -17.15 | 13.58 | 7.94 |
| Aurobindo Pharma | -0.91 | -2.76 | 6.97 | 12.33 | 0.80 | 42.10 | 4.65 |
| Alkem Laboratories | 1.07 | -0.98 | 1.04 | 17.54 | 11.22 | 23.21 | 14.59 |
| Biocon | 2.01 | -3.43 | -1.64 | 2.55 | -3.23 | 16.30 | -1.78 |
| Abbott India | -0.81 | -3.66 | -4.69 | -16.22 | -7.87 | 9.41 | 13.62 |
| Glenmark Pharmaceuticals | -2.23 | -6.68 | 8.65 | -4.43 | 28.04 | 71.29 | 31.42 |
| Laurus Labs | 2.09 | -12.70 | 0.28 | 17.55 | 53.63 | 43.95 | 22.52 |
| GlaxoSmithKline Pharmaceuticals | 4.74 | 2.16 | -3.07 | -6.27 | 13.91 | 26.53 | 11.47 |
| Anthem Biosciences | 12.46 | 2.67 | -3.42 | -10.30 | -7.83 | -2.68 | -1.62 |
| Ipca Laboratories | -0.97 | -3.89 | 10.08 | 4.61 | -3.40 | 19.14 | 8.42 |
| Ajanta Pharma | 2.52 | 0.03 | 13.00 | 9.11 | 6.12 | 33.94 | 18.79 |
| Gland Pharma | 2.15 | 10.35 | 1.32 | -3.67 | 24.33 | 12.94 | -4.08 |
Over the last one year, Piramal Pharma has declined 28.12% compared to peers like Sun Pharmaceutical Industries (-2.57%), Divi's Laboratories (-0.39%), Torrent Pharmaceuticals (22.66%). From a 5 year perspective, Piramal Pharma has underperformed peers relative to Sun Pharmaceutical Industries (21.85%) and Divi's Laboratories (10.09%).
Piramal Pharma Financials
Piramal Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 159.2 | 158.53 |
| 10 | 156.28 | 158.17 |
| 20 | 159.35 | 160.48 |
| 50 | 169.38 | 168.91 |
| 100 | 183.06 | 178.48 |
| 200 | 192.62 | 188.32 |
Piramal Pharma Share Holding Pattern
In the latest quarter, Piramal Pharma remained same as its previous close in promoter holding, while DII stake increased to 15.68%, FII holding fell to 29.66%, and public shareholding moved down to 19.35% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Piramal Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 9,00,00,000 | 1.61 | 1,549.89 | |
| 2,82,80,607 | 1.84 | 487.02 | |
| 97,76,924 | 0.89 | 168.37 | |
| 67,12,333 | 0.88 | 115.59 | |
| 61,54,389 | 1.26 | 105.98 | |
| 31,50,000 | 0.48 | 54.25 | |
| 29,00,000 | 0.55 | 49.94 | |
| 24,00,000 | 0.38 | 41.33 | |
| 21,34,646 | 0.74 | 36.76 | |
| 17,81,202 | 0.19 | 30.67 |
* Excluding Index & Arbitrage Funds
Piramal Pharma Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Piramal Pharma Options
Piramal Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Feb 06, 2026, 4:46 AM IST | Piramal Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Feb 05, 2026, 4:02 PM IST | Piramal Pharma - Announcement under Regulation 30 (LODR)-Change in Management |
| Jan 30, 2026, 11:28 PM IST | Piramal Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Jan 29, 2026, 10:23 PM IST | Piramal Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Jan 29, 2026, 5:48 AM IST | Piramal Pharma - Appointment of Company Secretary and Compliance Officer |
About Piramal Pharma
Piramal Pharma Ltd. is a Public Limited Listed company incorporated on 04/03/2020 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U24297MH2020PLC338592 and registration number is 338592. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 5285.71 Cr. and Equity Capital is Rs. 1324.35 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressGround Floor, Piramal Ananta, Agastya Corporate Park, Mumbai Maharashtra 400070
- Contact
Management
- Mrs. Nandini PiramalChairperson
- Mr. Peter DeYoungExecutive Director
- Mr. Vivek ValsarajExecutive Director & CFO
- Mr. Nathalie LeitchNon Executive Director
- Mr. S RamadoraiIndependent Director
- Mr. Peter StevensonIndependent Director
- Ms. Vibha Paul RishiIndependent Director
- Mr. Jairaj PurandareIndependent Director
- Mr. Sridhar GorthiIndependent Director
FAQs on Piramal Pharma Share Price
What is the share price of Piramal Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Piramal Pharma is ₹162.85 as on Feb 09, 2026.
What kind of stock is Piramal Pharma?
The Piramal Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Piramal Pharma?
The market cap of Piramal Pharma is ₹21,646.81 Cr as on Feb 09, 2026.
What are today's High and Low prices of Piramal Pharma?
Today’s highest and lowest price of Piramal Pharma are ₹163.25 and ₹158.45.
What are the 52 Week High and 52 Week Low of Piramal Pharma?
The 52-week high/low is the highest and lowest price at which Piramal Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Piramal Pharma is ₹241.00 and 52-week low of Piramal Pharma is ₹148.30 as on Feb 09, 2026.
How has the Piramal Pharma performed historically in terms of returns?
The Piramal Pharma has shown returns of 2.65% over the past day, -9.95% for the past month, -18.17% over 3 months, -28.12% over 1 year, 19.36% across 3 years, and -2.76% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Piramal Pharma?
P/E ratio of and PB ratio of Piramal Pharma are -132.40 and 2.68 on Feb 09, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse